Form 10-Q Kite Pharma, Inc. For: Jun 30
http://archive.fast-edgar.com/20140814/AFAZBG2CZ222KZ34222I2ZZ2GVM9ZY22ZZ62
Filed on: August 14, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shiba Inu Price Prediction: SHIB Bulls Target a Recovery as Remittix Approaches Its Final Presale Phase
- Solana and Aerodrome Price Prediction: AERO Gains 15% as Remittix Builds Toward Its Exchange Launch
- New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share